Moneycontrol PRO
HomeHealth & FitnessCervical cancer causes, treatment: Radiation therapy, with chemotherapy, is the best option

Cervical cancer causes, treatment: Radiation therapy, with chemotherapy, is the best option

Cervical cancer treatment: By emphasising effective prevention strategies, early detection initiatives, and the judicious application of available treatment modalities, the collective goal is to enhance the quality of life for individuals affected by cervical cancer in India.

April 22, 2024 / 08:51 IST
Chemotherapy plays a crucial role in managing advanced cervical cancer, either as a standalone treatment or in combination with radiation therapy (Image: Canva)

Cervical cancer stands as a formidable health challenge among Indian women, ranking as the second most common cancer and comprising a substantial portion, 18.3 percent, of new cancer cases in 2020. The gravity of the situation is further underscored by the estimation that approximately 1 in 53 Indian women will confront cervical cancer during their lifetime. To combat this disease effectively, a multifaceted approach to treatment is essential, incorporating surgery, radiation therapy, chemotherapy, and emerging immunotherapeutic interventions.

Surgery emerges as a cornerstone in the management of cervical cancer, particularly in its early stages, says Dr Kanav Kumar, Surgical Oncologist at the Punyashlok Ahilyadevi Holkar Head & Neck Cancer Institute of India, Mumbai.

According to him, the standard surgical procedure involves a comprehensive approach, entailing the removal of the uterus, ovaries, and regional lymph nodes — a procedure known as hysterectomy and pelvic lymph node dissection. However, in cases where fertility preservation is a concern, alternative approaches such as fertility-sparing surgeries may be considered, which involve removing only the cervix along with a cuff of surrounding tissue.

Despite the potential benefits of minimally invasive techniques like laparoscopy and robot-assisted surgeries, their widespread adoption remains limited due to conflicting reports regarding their long-term efficacy and outcomes.

Radiation therapy

Radiation therapy, either alone or in combination with chemotherapy (chemoradiation), serves as a primary treatment modality for locally advanced cervical cancer, says Kumar.

This therapeutic approach can be administered externally over a period of several weeks or internally through brachytherapy, delivering high-dose radiation directly to the site of the primary tumor. While radiation therapy has demonstrated comparable efficacy to surgery, especially in cases of early-stage cervical cancer, the choice between these modalities may hinge on factors such as age and concerns about long-term side effects.

According to Kumar, technological advancements in radiation therapy, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), enable precise targeting of tumors while minimizing damage to surrounding healthy tissue, thereby enhancing treatment outcomes and reducing treatment-related toxicity.

Chemotherapy

Chemotherapy plays a crucial role in managing advanced cervical cancer, either as a standalone treatment or in combination with radiation therapy, says Kumar.

Cisplatin, a commonly used chemotherapeutic agent, acts as a radiosensitiser when administered concurrently with radiation therapy, thereby augmenting treatment efficacy. However, the emergence of immunotherapy as a promising therapeutic avenue has sparked considerable interest in its potential role in the treatment of cervical cancer. Immunotherapy harnesses the body's immune system to recognize and destroy cancer cells more effectively, with fewer side effects compared to traditional chemotherapy.

While immunotherapy has demonstrated efficacy in certain cases of metastatic cervical cancer, its role in treating locally advanced disease remains an area of ongoing research and debate. Affordability also poses a significant barrier to the widespread adoption of immunotherapy, with costs averaging between Rs 1.5-4.5 lakhs per session.

Nivedita is a Delhi-based journalist who writes on health, fashion, lifestyle and entertainment. Views expressed are personal.
first published: Apr 22, 2024 08:50 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347